Key circRNA Identification of Postoperative Delirium in Elderly Patients Undergoing Cardiac Surgery

Postoperative Delirium Clinical Trial

Official title:

Key circRNA Identification of Postoperative Delirium in Elderly Patients Undergoing Cardiac Surgery

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05743660
• Other study ID #: XuzhouCH20220629
• Status: Recruiting
• Start date: June 30, 2022
• Est. completion date: September 30, 2023

Study information

• Verified date: February 2023
• Source: Xuzhou Central Hospital
• Contact: Yangzi Zhu, Doctor
• Phone: +86 18168779150
• Email: zhuyz[@]188.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The observational study aims to discover differentially expressed circRNAs in the peripheral blood of patients with postoperative delirium, which aims to answer the main questions at:

Whether there are changes in circRNA expression in peripheral blood in elderly patients with delirium after cardiopulmonary bypass surgery? Whether the circRNA with altered expression plays an important role in the occurrence and development of POD? What are the functions and underlying mechanisms of circRNA with altered expression in POD? Voluntary patients will receive follow-up 1 day before and 7 days after surgery to assess their cognitive function, and peripheral blood will be collected 1 day before and 3 days after surgery. The study divided patients into POD group and non-POD group according to whether delirium occurred within 7 days after surgery.

Description:

Investigators combined qRT-PCR by performing circRNAs chip analysis to study differential expression of circRNAs in plasma samples of elderly patients with non-POD who underwent cardiac surgery under general anesthesia and cardiopulmonary bypass. Subsequently, miRNA binding sites and associated mRNAs are predicted by bioinformatics analysis. Moreover, we plan to construct predicted circN-MIRNA-MRNA co-expression networks to study the main functions and pathways of target genes, thereby attempting to provide a preliminary view of the potential role of a circRNA in POD. The study may provide an important perspective on the differential expression of circRNA in patients with POD, and may also provide insights into biomarkers and therapeutic targets of POD.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50
• Est. completion date: September 30, 2023
• Est. primary completion date: May 30, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 50 Years to 90 Years

Eligibility

Inclusion Criteria:

1. Be over 50 years old;

2. ASA Grade I-III;

3. Heart surgery is planned under general anesthesia.

Exclusion Criteria:

1. Patients with the second surgery;

2. The ejection fraction is less than 40%;

3. The score of the preoperative simple mental status examination (MMSE) is less than 24 points;

4. Patients with mental illness or central nervous system disease;

5. Patients who cannot or refuse to complete MMSE before surgery.

Related Conditions & MeSH terms

• Delirium
• Postoperative Delirium

Locations

Country	Name	City	State
China	Xuzhou Central Hospital	Xuzhou	Jiangsu

Sponsors (1)

Lead Sponsor	Collaborator
Xuzhou Central Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Differences in circRNA microarrays before and after surgery	Plasma was isolated from peripheral blood, RNA samples were prepared, and circRNA microarray analysis was performed. The differences in circRNA expression in peripheral blood of POD patients and non-POD patients were comprehensively analyzed.	1 day before surgery,3 day after surgery
Primary	3-minute Diagnostic Interview for CAM	Postoperative delirium was assessed by 3-minute Diagnostic Interview for confusion assessment method (CAM).	Consecutive 7 days after the surgery